EGFR and nasopharyngeal carcinoma: A study showed that the positive rate of EGFR expression in primary nasopharyngeal carcinoma and metastatic lymph nodes was 73.3% and 60.5%, respectively, and the difference in the expression level between primary and positive lymph nodes was statistically significant (P=0.001) (21).